ICN Biomedicals Inc.: The Costa Mesa biotechnology...
- Share via
ICN Biomedicals Inc.: The Costa Mesa biotechnology and diagnostic products company said that net income for the first quarter dropped 42% to $1.1 million from $1.9 million for last year’s first quarter. Sales for the quarter ended Feb. 28 declined 10% to $29.7 million from $32.9 million a year earlier.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
